Growing the love for investing
Results 21 - 30 of 545 : Previous 1 2 3 4 5 6 7 8 9 Next
Buy, Sell, or Hold: Human Genome Sciences
In a battle of risk versus reward, let's see which one comes out on top.
3 Lessons From the J.P. Morgan Health-Care Confab
After 30 years, the conference still offers useful takeaways.
This mechanical strategy might cast a winning spell
A disastrous move at the end of 2011.
The Sector That's Delivering 2012's Biggest Winners
It's health care.
Stocks Shaking the Investment World
These stocks caused the markets to tremble this past month.
Could This Stock Nearly Double 2 Years In a Row?
Up 96% in 2011, there's a decent chance at a Jazz repeat in 2012.
Human Genome Sciences needs to accelerate growth.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK